DNAPrint Genomics, Inc. Stock OTC Bulletin Board
Equities
DNAG
US23324Q2021
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
Financials (USD)
Sales 2005 | 1.28M | Sales 2006 | 2.43M | Capitalization | 3.79M |
---|---|---|---|---|---|
Net income 2005 | -8M | Net income 2006 | -12M | EV / Sales 2005 | 1.89 x |
Net cash position 2005 | 737K | Net cash position 2006 | 1.21M | EV / Sales 2006 | 1.06 x |
P/E ratio 2005 |
-0.23
x | P/E ratio 2006 |
-0.27
x | Employees | - |
Yield 2005 * |
-
| Yield 2006 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Monica Tamborini
DFI | Director of Finance/CFO | - | - |
1st Jan change | Capi. | |
---|---|---|
+26.34% | 42.68B | |
-3.87% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.63% | 24.94B | |
-21.44% | 18.96B | |
+27.60% | 12.3B | |
-2.96% | 11.95B | |
-1.78% | 11.55B |
- Stock Market
- Equities
- DNAG Stock
- DNAG Stock